Guillain-Barré Syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and their variants, such as Multifocal Motor Neuropathy (MMN), are rare conditions that are paralyzing and potentially catastrophic inflammatory disorders of the peripheral nerves. GBS, CIDP, and MMN have a slow and unpredictable recovery. Earlier diagnosis, treatment, and access to rehabilitation services can significantly improve the chances of avoiding permanent lifelong residual damage to the nerves. Our vision is that every person affected by GBS, CIDP, or variants such as MMN will have access to early and accurate diagnosis, expert interdisciplinary treatment, and support, and through continued research, a cure will be developed.
GBS/CIDP Foundation of Canada was founded in 2003. We are a charitable, patient-centred organization that provides support, education, research, and advocacy so that no patient or family goes through GBS, CIDP, MMN, or their variants alone. The foundation has proudly established a National Medical Advisory Board of 16 Canadian neuromuscular specialists trained in diagnosing and treating our disorders and a network of trained volunteers providing peer-to-peer support and building critical community awareness nationwide.
Medical professionals are welcome to connect with the foundation for more information.
